πŸ‡ΊπŸ‡Έ FDA
Patent

US 7419962

3,6-bicyclolides

granted A61PA61P11/00A61P29/00

Quick answer

US patent 7419962 (3,6-bicyclolides) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61P, A61P11/00, A61P29/00, A61P31/04